Volume 27, Issue 2 (Avicenna Journal of Clinical Medicine-Summer 2020)                   Avicenna J Clin Med 2020, 27(2): 117-123 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rabiei S, Hedayat M, Fallah M. Comparison of Agonist and Antagonist of GnRH in Induction Ovulation in Infertile Couples with Male Factor Referred to Fatemieh Hospital of Hamadan. Avicenna J Clin Med 2020; 27 (2) :117-123
URL: http://sjh.umsha.ac.ir/article-1-2048-en.html
1- , rabiei@umsha.ac.ir
Abstract:   (8337 Views)
Background and Objective: Infertility and its treatment is one of the most important challenges that gynecology faced it. This study compares two methods of administration of GnRH agonists and GnRH antagonists on the occurrence of pregnancy.
Materials and Methods:  This study is a randomized controlled clinical trial. 84 infertile couples with male factor infertility problems referred to Fatemieh Hospital of Hamadan were enrolled in this study and randomly assigned to two groups of 42 cases, the first group treated with agonist GnRH (Bucereline) and the second one treated with GnRH antagonists (Cetrotide). Two groups regarding the incidence of pregnancy, number of oocytes obtained, the average days of induction and the number of fertilized oocytes, the incidence of OHSS syndrome and treatment costs were compared.
Results: Findings showed that the clinical pregnancy rate in the agonist group, 19 cases (45.23%) and the antagonist group, 7 cases (16.67%) has been observed. The difference was statistically significant (P<0.009). Number of fertilized oocytes in agonist group was significantly higher than antagonist (P<0.004) and the average induction days in the antagonist group was significantly lower (P<0.001). The difference between incidence of OHSS syndrome and the overall cost of treatment in both groups was not significant.
Conclusion: We suggested  that the efficacy of agonist drugs in occurrence of pregnancy are much better than antagonist drugs even though the complications do not differ in both groups.
Full-Text [PDF 849 kb]   (1384 Downloads)    
Type of Study: Original | Subject: Obstetrics & Gynecology

1. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 17th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. P. 1215-32.
2. Danforth DN. Danforth's obstetrics and gynecology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. P. 705
3. Berek JS, Adashi EY, Hillard PA. Novak's gynecology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. P. 1238-87.
4. Surrey ES. Management of the poor responder: the role of GnRH agonists and antagonists. J Assist Reprod Genet. 2007;24(12):613-9. PMID: 18046641 DOI: 10.1007/s10815-007-9180-3
5. Huang SY, Huang HY, Yu HT, Wang HS, Chen CK, Lee CL, et al. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer. Taiwan J Obstet Gynecol. 2011;50(4):432-5. PMID: 22212313 DOI: 10.1016/j.tjog.2011.10.006
6. Li Y, Li Y, Lai Q, Zhang H, Zhu G, Jin L, et al. Comparison between a GnRH agonist and a GnRH antagonist protocol for same patient undergoing IVF. J Huazhong Univ Sci Technolog Med Sci. 2008;28(5):618-20. PMID: 18846352 DOI: 10.1007/s11596-008-0529-3
7. Del Gadillo JC, Siebzehnrübl E, Dittrich R, Wildt L, Lang N. Comparison of GnRH agonist and antagonists in unselected IVF/ICSI patients treated with different controlled ovarian hyperstimulation protocols: a matches study. Eur J Obstet Gynecol Reprod Biol. 2002;102(2):179-83. PMID: 11950487 DOI: 10.1016/s0301-2115(01)00580-2
8. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin –releasing hormone antagonists for assisted conception: a cochrane review. Reprod Biomed Online. 2006; 14(5):640-64
9. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin –releasing hormone antagonists for assisted conception. Reprod Biomed Online. 2006;12(3):534-9. PMID: 17509210 DOI: 10.1016/s1472-6483(10)61059-0
10. Kim CH, You RM, Kang HJ, Ahn JW, Jeon I, Lee JW, et al. GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI. Clin Exp Reprod Med. 2011;38(4):228-33. PMID: 22384447 DOI: 10.5653/cerm.2011.38.4.228
11. Takahashi K, Mukaida T, Tomiyama T, Goto T, Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI with a GnRH agonist protocol. J Assist Reprod Genet. 2004;21(9):317-22. PMID: 15587144 DOI: 10.1023/b:jarg.0000045470.68525.a4
12. Madani T, Ashrafi M, Yeganeh LM. Comparison of different stimulation protocols efficacy in poor responders undergoing IVF: a retrospective study. Gynecol Endocrinol. 2012;28(2):102-5. PMID: 22263965 DOI: 10.3109/09513590.2011.579206
13. Kovacs P, Sajgo A, Kaali SG, Pal L. Detrimental effects of high dose gonadotropin on outcome of ivf: making a case for gentle ovarian stimulation strategies. Reprod Sci. 2012;19(7):718-24. PMID: 22378863 DOI: 10.1177/1933719111432859
14. Berin I, Stein DE, Keltz MD. Comparison of GnRH antagonist and GnRH agonists flare protocols for poor responders undergoing in vitro fertilization. Fertil Steril. 2010;93(2):360-3. PMID: 19131055 DOI: 10.1016/j.fertnstert.2008.11.007
15. Nikolettos N, Al-Hasani S, Felberbaum R, Demirel LC, Kupker W, Montzka P, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol. 2001;97(2):202-7. PMID: 11451549 DOI: 10.1016/s0301-2115(00)00535-2
16. Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome. Hum Reprod. 2005;20(9):2421-5. DOI: 10.1093/humrep/dei074
17. Pundir J, Sunkara SK, El-Toukhy T, Khalaf Y. Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? Reprod Biomed Online. 2012;24(1):6-22. PMID: 22133908 DOI: 10.1016/j.rbmo.2011.09.017

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Avicenna Journal of Clinical Medicine

Designed & Developed by : Yektaweb